Also trades as: 4506.T (JPX) · $vol 41M · SMDPY (OTC) · $vol 0M

$9.79

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 68 · $4.4B mcap · 211M float · 0.0000% daily turnover · Short 80% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$456.1B +14.4% ▲

5Y CAGR: -2.4%

Gross Profit

$258.5B +5.3% ▲

5Y CAGR: -7.3%

Operating Income

$50.7B +239.4% ▲

5Y CAGR: -6.6%

Net Income

$107.5B +355.0% ▲

5Y CAGR: +13.9%

EPS (Diluted)

$270.03 +353.9% ▲

5Y CAGR: +13.8%

EBITDA

$71.6B +85.5% ▲

5Y CAGR: -1.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$560.0B	$555.5B	$314.6B	$398.8B	$456.1B
YoY Growth	+8.5%	-0.8%	-43.4%	+26.8%	+14.4%
Cost of Revenue	$157.1B	$178.9B	$126.6B	$153.4B	$197.6B
Gross Profit	$402.9B	$376.6B	$188.0B	$245.4B	$258.5B
Gross Margin	71.9%	67.8%	59.8%	61.5%	56.7%
R&D Expenses	$94.9B	$131.9B	$112.6B	$49.9B	$44.3B
SG&A Expenses	$217.3B	$339.2B	$429.5B	$160.4B	$163.6B
Operating Expenses	$342.7B	$453.6B	$542.8B	$230.5B	$207.9B
Operating Income	$60.2B	-$77.0B	-$354.9B	$14.9B	$50.7B
Operating Margin	10.8%	-13.9%	-112.8%	3.7%	11.1%
Interest Expense	$3.0B	$3.2B	$4.3B	$13.5B	$10.3B
Income Before Tax	$83.0B	-$47.9B	-$323.1B	$17.6B	$101.0B
Tax Expense	$42.4B	$48.8B	-$8.2B	-$6.0B	-$6.6B
Net Income	$56.4B	-$74.5B	-$315.0B	$23.6B	$107.5B
Net Margin	10.1%	-13.4%	-100.1%	5.9%	23.6%
EPS (Diluted)	$141.99	$-187.55	$-792.79	$59.49	$270.03
EBITDA	$98.3B	-$3.5B	-$317.4B	$38.6B	$71.6B
Shares Outstanding	397M	397M	397M	397M	397M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$90.7B	$90.1B	$112.4B	$105.6B	$108.0B	$120.8B	$120.7B	$106.2B
Cost of Revenue	$34.9B	$37.4B	$41.4B	$39.7B	$44.1B	$46.2B	$55.5B	$51.6B
Gross Profit	$55.7B	$52.7B	$71.0B	$66.0B	$63.9B	$74.6B	$65.2B	$54.6B
Gross Margin	61.5%	58.5%	63.1%	62.5%	59.2%	61.7%	54.0%	51.4%
R&D Expenses	$13.1B	$13.1B	$10.5B	$13.2B	$8.2B	$9.5B	$10.4B	$16.2B
SG&A Expenses	$45.4B	$44.6B	$41.0B	$29.3B	$35.7B	$41.5B	$43.0B	$43.3B
Operating Expenses	$58.8B	$57.4B	$49.6B	$64.3B	$43.5B	$51.0B	$53.3B	$59.6B
Operating Income	-$3.1B	-$4.7B	$21.4B	$1.7B	$20.4B	$23.6B	$11.9B	-$4.9B
Operating Margin	-3.4%	-5.3%	19.0%	1.6%	18.9%	19.5%	9.9%	-4.6%
Interest Expense	$2.0B	$44.5B	$0	$22.0B	$8.5B	$0	$5.1B	$463M
Income Before Tax	$17.2B	-$49.6B	$56.4B	-$6.4B	$11.9B	$82.0B	$8.7B	-$1.2B
Tax Expense	$1.3B	-$1.4B	$3.0B	-$8.8B	$726M	-$6.9B	-$80M	-$385M
Net Income	$15.9B	-$48.2B	$53.4B	$2.4B	$11.2B	$88.9B	$8.8B	-$817M
Net Margin	17.6%	-53.5%	47.5%	2.3%	10.4%	73.6%	7.3%	-0.8%
EPS (Diluted)	$40.11	$-121.24	$134.53	$6.08	$28.21	$224.00	$22.21	$-2.06
EBITDA	$3.8B	$1.7B	$27.5B	$5.6B	$26.2B	$87.4B	$19.2B	$90M
Shares Outstanding	397M	397M	397M	397M	397M	397M	397M	397M

DNPUF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet